These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27977588)

  • 21. Predictive value of bone marrow megakaryocyte count for immunotherapeutic response in primary Sjögren's syndrome patients with severe immune thrombocytopenia: A single-center case-control study in China.
    Zhong H; Xue Y; Zhang L; Yang Y; Zhou J; Zhang S; Jiang N; Qiao L; Peng L; Wang L; Zhang W; Xu D; Li M; Zhao Y; Zeng X
    Int J Rheum Dis; 2023 Jul; 26(7):1260-1267. PubMed ID: 37183556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
    Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
    Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
    Zhou EM; Shen H; Wang D; Xu W
    PeerJ; 2024; 12():e17152. PubMed ID: 38666084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
    Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
    Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ; Kelder JC
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
    Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
    Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
    Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
    Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
    J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
    Zimmerman SA; Ware RE
    J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Sjögren's syndrome.
    Bowman SJ
    Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2010 Sep; 63(3):526-8. PubMed ID: 20708475
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.
    Samuel H; Nardi M; Karpatkin M; Hart D; Belmont M; Karpatkin S
    Br J Haematol; 1999 Jun; 105(4):1086-91. PubMed ID: 10554825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset.
    Baer AN; Maynard JW; Shaikh F; Magder LS; Petri M
    J Rheumatol; 2010 Jun; 37(6):1143-9. PubMed ID: 20360189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
    Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
    RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome.
    Matorras R; Ocerin I; Unamuno M; Nieto A; Peiró E; Burgos J; Expósito A
    Lupus; 2007; 16(9):736-40. PubMed ID: 17728368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.